KAO JOHN E sold $356K of ALHC (indirect holdings)

KAO JOHN E (Chief Executive Officer) sold 27,400 indirectly-held shares of Alignment Healthcare, Inc. (ALHC) at $13.00 ($0.36M total) on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KAO JOHN E
Published Sep 16, 2026, 9:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Bearish
medium confidence
Mentioned
$ALHC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBearishLow
01

Why it matters

Insider sales often lead to short‑term price weakness, especially for small caps.

02

Market read

The filing provides fresh insider‑sale data that may affect trader sentiment on ALHC.

03

What to watch

The CEO's remaining stake remains sizable, and the sale was pre‑planned.

Relevance 3/10Novelty 5/10Timing: filed Sep 16 2026

Background

Alignment Healthcare Inc. (ALHC) filed a Form 4 reporting the CEO's sale of shares under a 10b5‑1 plan.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

CEO sold 27,400 shares for $356,200 via a 10b5-1 plan, reducing his stake to 590,766 shares.

Expected impact

modest short‑term downside pressure

Evidence & confidence

A $356K sale by the CEO is material for a micro‑cap and often triggers sell‑offs.

Market effects

Minimal impact on the broader healthcare sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a routine liquidity event under a pre‑arranged plan, not a negative signal.

Key entities

  • Alignment Healthcare, Inc.

    US‑listed healthcare firm (NASDAQ: ALHC).

  • John E. Kao

    Chief Executive Officer of Alignment Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.